AAOS 2022: Transmuscular Quadratus Lumborum in Hip Arthroscopy .
Transmuscular Quadratus Lumborum Block Does Not Provide Any Benefit for Primary Hip Arthroscopy
One hundred and two patients undergoing hip arthroscopy were randomized to receive a transmuscular quadratus lumborum block (TQLB, n=51) with pericapsular injection or pericapsular injection alone (n=51). The primary outcomes of interest was the numerical rating scale (NRS). Secondary outcomes of interest included opioid utilization in the PACU, PACU recovery time, quadriceps strength and adverse events. There was no significant difference in initial PACU pain scores between groups. Similarly, PACU opioid consumption, total time spent in the PACU and quadriceps strength was similar between groups. No differences in adverse events were noted.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
